Publication:
Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.

dc.contributor.authorForouhi, Nita G
dc.contributor.authorImamura, Fumiaki
dc.contributor.authorSharp, Stephen J
dc.contributor.authorKoulman, Albert
dc.contributor.authorSchulze, Matthias B
dc.contributor.authorZheng, Jusheng
dc.contributor.authorYe, Zheng
dc.contributor.authorSluijs, Ivonne
dc.contributor.authorGuevara, Marcela
dc.contributor.authorHuerta, José María
dc.contributor.authorKröger, Janine
dc.contributor.authorWang, Laura Yun
dc.contributor.authorSummerhill, Keith
dc.contributor.authorGriffin, Julian L
dc.contributor.authorFeskens, Edith J M
dc.contributor.authorAffret, Aurélie
dc.contributor.authorAmiano, Pilar
dc.contributor.authorBoeing, Heiner
dc.contributor.authorDow, Courtney
dc.contributor.authorFagherazzi, Guy
dc.contributor.authorFranks, Paul W
dc.contributor.authorGonzalez, Carlos
dc.contributor.authorKaaks, Rudolf
dc.contributor.authorKey, Timothy J
dc.contributor.authorKhaw, Kay Tee
dc.contributor.authorKühn, Tilman
dc.contributor.authorMortensen, Lotte Maxild
dc.contributor.authorNilsson, Peter M
dc.contributor.authorOvervad, Kim
dc.contributor.authorPala, Valeria
dc.contributor.authorPalli, Domenico
dc.contributor.authorPanico, Salvatore
dc.contributor.authorQuirós, J Ramón
dc.contributor.authorRodriguez-Barranco, Miguel
dc.contributor.authorRolandsson, Olov
dc.contributor.authorSacerdote, Carlotta
dc.contributor.authorScalbert, Augustin
dc.contributor.authorSlimani, Nadia
dc.contributor.authorSpijkerman, Annemieke M W
dc.contributor.authorTjonneland, Anne
dc.contributor.authorTormo, Maria-Jose
dc.contributor.authorTumino, Rosario
dc.contributor.authorvan der A, Daphne L
dc.contributor.authorvan der Schouw, Yvonne T
dc.contributor.authorLangenberg, Claudia
dc.contributor.authorRiboli, Elio
dc.contributor.authorWareham, Nicholas J
dc.contributor.authoraffiliation[Forouhi,NG; Imamura,F; Sharp,SJ; Zheng,J; Ye,Z; Langenberg,C; Wareham,NJ] MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom. [Koulman,A; Wang,LY; Summerhill,K; Griffin,JL] MRC Human Nutrition Research, Cambridge, UK. [Schulze,MB; Kröger,J; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany. [Sluijs,I; van der Schouw,YT] University Medical Center Utrecht, Utrecht, the Netherlands. [Guevara,M] Navarre Public Health Institute (ISPN), Pamplona, Spain. [Guevara,M; Huerta,JM; Amiano,P; Rodriguez-Barranco,M; Tormo,M] CIBER Epidemiología y Salud Pública (CIBERESP), Spain. [Huerta,M; Tormo,M] Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain. [Feskens,EJM] Wageningen University, The Netherlands. [Affret,A; Dow,C; Fagherazzi,G] Inserm, CESP, U1018, Villejuif, France. Univ Paris-Sud, Villejuif, France, Gustave Roussy Institute, Villejuif, France. [Amiano,P] Public Health Division of Gipuzkoa, San Sebastian, Spain. Instituto BIO-Donostia, Basque Government, San Sebastian, Spain. [Boeing,H] German Institute of Human Nutrition Potsdam-Rehbruecke, Germany. [Franks,PW; Nilsson,PM] Lund University, Malmö, Sweden. [Franks,PW; Rolandsson,O] Umeå University, Umeå, Sweden. [Gonzalez,C] Catalan Institute of Oncology (ICO), Barcelona, Spain. [Kaaks,R; Kühn1,T] German Cancer Research Centre (DKFZ), Heidelberg, Germany. [Key1,TJ] University of Oxford, Oxford, United Kingdom. [Khaw,KT] University of Cambridge, Cambridge, United Kingdom. [Mortensen,M] Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. [Mortensen,M; Overvad,K] Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark. [Overvad,K] Aalborg University Hospital, Aalborg, Denmark. [Pala,V] Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Palli,D] Cancer Research and Prevention Institute (ISPO), Florence, Italy. [Panico,S] Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy. [Quirós,JR] Public Health Directorate, Asturias, Spain. [Rodriguez-Barranco,M] Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain. [Sacerdote,C] Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Turin, Italy. Human Genetics Foundation (HuGeF), Turin, Italy. [Scalbert,A; Slimani,N] International Agency for Research on Cancer, Lyon, France. [Spijkerman,AMW; van der A,DL] National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. [Tjonneland,A] Danish Cancer Society Research Center, Copenhagen, Denmark. [Tormo,MJ] Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain. [Tumino,R] Cancer Registry and Histopathology Unit, Civic and M.P.Arezzo Hospital, ASP Ragusa, Italy. [Riboli,E] School of Public Health, Imperial College London, London, United Kingdom.es
dc.contributor.funderFunding for the InterAct project was provided by the EU FP6 programme (grant number LSHM_CT_2006_037197).
dc.date.accessioned2016-09-06T11:20:32Z
dc.date.available2016-09-06T11:20:32Z
dc.date.issued2016-07-19
dc.descriptionJournal Article;es
dc.description.abstractBACKGROUND Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88-0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77-0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85-0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. CONCLUSIONS These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class.es
dc.description.versionYeses
dc.identifier.citationForouhi NG, Imamura F, Sharp SJ, Koulman A, Schulze MB, Zheng J, et al. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study. PLoS Med. 2016; 13(7): e1002094es
dc.identifier.doi10.1371/journal.pmed.1002094
dc.identifier.essn1549-1676
dc.identifier.issn1549-1277
dc.identifier.pmcPMC4951144
dc.identifier.pmid27434045
dc.identifier.urihttp://hdl.handle.net/10668/2395
dc.journal.titlePLoS Medicine
dc.language.isoen
dc.publisherPublic Library of Sciencees
dc.relation.publisherversionhttp://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002094#abstract0es
dc.rights.accessRightsopen access
dc.subjectDiabetes Mellitus Tipo 2es
dc.subjectÁcidos Grasos Omega-6es
dc.subjectÁcidos Grasos Insaturadoses
dc.subjectFosfolípidoses
dc.subjectPlasmaes
dc.subjectÁcido 8,11,14-eicosanoicoes
dc.subjectÁcido araquidónicoes
dc.subjectCromatografía de gaseses
dc.subjectDietaes
dc.subjectÁcidos docosahexaenoicoses
dc.subjectÁcido eicosapentaenoicoes
dc.subjectEuropaes
dc.subjectÁcidos grasos omega 3es
dc.subjectÁcido linoleicoes
dc.subjectEstudios prospectivoses
dc.subject.meshMedical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus, Type 2es
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Omega-6es
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturatedes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Phospholipidses
dc.subject.meshMedical Subject Headings::Anatomy::Fluids and Secretions::Body Fluids::Blood::Plasmaes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Eicosanoids::8,11,14-Eicosatrienoic Acides
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Arachidonic Acidses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Chemistry Techniques, Analytical::Chromatography::Chromatography, Gases
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Dietes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Omega-3::Docosahexaenoic Acidses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Omega-3::Eicosapentaenoic Acides
dc.subject.meshMedical Subject Headings::Geographicals::Geographic Locations::Europees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Omega-3es
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Omega-6::Linoleic Acidses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studieses
dc.titleAssociation of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 5 of 15
Loading...
Thumbnail Image
Name:
Forouhi_AssociationOfPlasma.PDF
Size:
534.86 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Loading...
Thumbnail Image
Name:
Forouhi_AssociationOfPlasmaS1Fig.PDF
Size:
78.29 KB
Format:
Adobe Portable Document Format
Description:
S1 Fig.
Loading...
Thumbnail Image
Name:
Forouhi_AssociaationOfPlasmaS2Fig.PDF
Size:
23.35 KB
Format:
Adobe Portable Document Format
Description:
S2 Fig.
Loading...
Thumbnail Image
Name:
Forouhi_AssociationOfPlasmaS3Fig.PDF
Size:
83.21 KB
Format:
Adobe Portable Document Format
Description:
S3 Fig.
No Thumbnail Available
Name:
Forouhi_AssociationOfPlasmaS1Prisma.DOC
Size:
74 KB
Format:
Microsoft Word
Description:
S1Prisma